Our investment areas:
- Seed Investments: Identifying, building and investing in exceptional Nordic startups
- Venture Investments: Private and public venture investing
- Growth Investments: Supporting high-growth life science companies
- Principal Investments: Sizable investments in established life science companies
- Capital Investments: Our investments outside the life sciences
Holdings and investments
Novo Holdings is a holding and investment company that is responsible for managing the assets and wealth of the Novo Nordisk Foundation, one of the world’s largest enterprise foundations.
Novo Holdings is the controlling shareholder of Novo Nordisk and Novozymes and manages an investment portfolio, with a long-term return perspective. In addition to managing a broad portfolio of equities, bonds, real estate, infrastructure and private equity assets, Novo Holdings is a world-leading life science investor. Through its Seeds, Venture, Growth and Principal Investments teams, Novo Holdings invests in life science companies at all stages of development.
As of year-end 2022, Novo Holdings had total assets of EUR 108 billion.